THC Farmaceuticals Inc
OTC:CBDG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zhejiang Renzhi Co Ltd
SZSE:002629
|
CN |
|
Hemisphere Properties India Ltd
NSE:HEMIPROP
|
IN |
|
S
|
Shenzhen TXD Technology Co Ltd
SZSE:002845
|
CN |
|
W
|
Wockhardt Ltd
NSE:WOCKPHARMA
|
IN |
|
P
|
Pony Group Inc
OTC:PNYG
|
CN |
|
9
|
9R Ltd
SGX:1Y1
|
SG |
|
Sakai Trading Co Ltd
TSE:9967
|
JP |
THC Farmaceuticals Inc
Total Assets
THC Farmaceuticals Inc
Total Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
THC Farmaceuticals Inc
OTC:CBDG
|
Total Assets
$2.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
UniFirst Corp
NYSE:UNF
|
Total Assets
$2.8B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
6%
|
|
|
VSE Corp
NASDAQ:VSEC
|
Total Assets
$2B
|
CAGR 3-Years
27%
|
CAGR 5-Years
21%
|
CAGR 10-Years
13%
|
|
|
Copart Inc
NASDAQ:CPRT
|
Total Assets
$10.6B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
|
Aurora Innovation Inc
NASDAQ:AUR
|
Total Assets
$2.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Cintas Corp
NASDAQ:CTAS
|
Total Assets
$10.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
THC Farmaceuticals Inc
Glance View
THC Farmaceuticals, Inc. engages in the research and development of cannabis pharmaceutical products. The company is headquartered in Scottsdale, Arizona. The company went IPO on 2012-08-22. The firm through its subsidiary CBDual Biotechnology Corp., a pharmaceutical start-up company focuses on developing products based on cannabidiol (CBD) and/or Tetrahydrocannabinol (THC). The firm is engaged cannabis formulations, edibles, and delivery systems of cannabis. The company manufactures and markets cannabis extract products made from cannabis. The firm's facility is located in Southern California. The company provides access for patients to participate in clinical trials of new medical cannabis medications, therapies, and products. The firm is focusing on the research of psilocybin for the purpose of conducting clinical trials involving the combination of genetic testing and micro-dosing of psilocybin formulations.
See Also
What is THC Farmaceuticals Inc's Total Assets?
Total Assets
2.8m
USD
Based on the financial report for Sep 30, 2022, THC Farmaceuticals Inc's Total Assets amounts to 2.8m USD.
What is THC Farmaceuticals Inc's Total Assets growth rate?
Total Assets CAGR 1Y
1%
Over the last year, the Total Assets growth was 1%.
